Genexine Market Cap

Genexine has a market cap or net worth of 259.69 billion as of April 28, 2026. Its market cap has increased by 46.60% in one year.

Market Cap

259.69B

Enterprise Value

n/a

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

5,600.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 259.69B, an increase of 138.20%. That is a compound annual growth rate of 5.36%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	259.69B	21.88%
Dec 30, 2025	213.07B	-12.27%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
JETEMA,	260.84B
EASY BIO,Inc.	261.68B
Bioneer	281.33B
HLB Therapeutics	323.97B
MedPacto	188.17B
Macrogen	183.22B
GC Cell	368.16B
BINEX	368.48B

Market Cap Rankings